Objective
to report the 2-year clinical outcomes of immediate complete revascularisation or staged complete revascularisation in patients with ACS
Study
international multicentre prospective non-inferiority trial (margin 4.0%)
Population
patients with ACS and multivessel disease
Endpoints
composite of all-cause death, MI, revascularisation and cerebrovascular event at 2 years
Conclusion
Among patients with ACS and multivessel disease, an immediate complete revascularisation strategy was not significantly different from staged complete revascularisation in terms of 2-year adverse clinical outcomes.
den Dekker et al. JACC Cardiovasc Interv. 2024;17(24):2866-2874.